At a glance
- Originator Nonindustrial source
- Class Antiarrhythmics; Ischaemic heart disorder therapies
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Angina pectoris; Arrhythmias
Most Recent Events
- 02 Apr 1997 No-Development-Reported for Angina pectoris in Japan (Unknown route)
- 02 Apr 1997 No-Development-Reported for Arrhythmias in Japan (Unknown route)
- 24 Oct 1994 Preclinical development for Angina pectoris in Japan (Unknown route)